about
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a modelThe PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathwaysEffect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activationFlagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cellsNitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signalingRhoA regulation of NF-kappaB activation is mediated by COX-2-dependent feedback inhibition of IKK in kidney epithelial cellsBiomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytesRelA/p65 regulation of IkappaBbeta.NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalphaMyoD-dependent regulation of NF-κB activity couples cell-cycle withdrawal to myogenic differentiationSuppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.Biomechanical signals inhibit IKK activity to attenuate NF-kappaB transcription activity in inflamed chondrocytes.Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation.Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
P2860
Q21143797-A992848E-77E9-4463-8DAF-9077A91B1033Q24337186-16F16A6C-2715-470B-8929-FCD0D1B62B08Q24670467-569BA7EB-F0CC-4FF3-A2E7-87B21BC83C08Q24805624-033C1C01-2CFD-4BBB-B3E3-81E89FE3F71CQ28471740-9403D621-A3BA-41DB-A60C-F5ECC398A174Q28572424-656B078A-9AA6-4E26-97E0-6FFE9ECD76D6Q28578466-18A6C632-B4C4-47D7-A87E-FAD430184212Q28593441-5BD8BA15-A8DC-4CBD-BDE3-43A702DFEE81Q33557568-205D6803-368C-42FD-AA18-DDBC45E7D874Q35973957-4F0E0414-8737-496C-AD34-37AC457F35C5Q36149126-0B605F6A-1522-49AF-81EE-E74BAECD93B0Q37108814-0678A6FF-6468-4375-82BE-10156B401088Q38289705-FB9063A9-29A7-422C-871D-9F5AFB3C6439Q40175734-BB7833C6-24C2-4135-AA91-0429CCDE56BBQ43004498-E5C86E99-4700-4F8B-A2BA-1A594848FC88Q46592704-FD723893-DB92-40FE-B958-939F80170373
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Assaying for I kappa B kinase activity.
@en
type
label
Assaying for I kappa B kinase activity.
@en
prefLabel
Assaying for I kappa B kinase activity.
@en
P1476
Assaying for I kappa B kinase activity.
@en
P2093
J A DiDonato
P304
P356
10.1016/S0076-6879(00)22038-7
P407
P577
2000-01-01T00:00:00Z